Third Quarter 2013 Financial highlights

October 25, 2013

Robust 3rd Quarter 2013 for BASF

Cautionary note regarding forward-looking statements

This presentation may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. BASF has based these forward-looking statements on its views and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and BASF does not undertake any duty to update the forwardlooking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations.

BASF Q3 2013 Analyst Conference Call October 25, 2013

Robust 3rd quarter 2013 for BASF

Business performance Sales EBITDA EBIT before special items EBIT Net income Reported EPS Adjusted EPS Operating cash flow Q313 17.7 billion 2.5 billion 1.7 billion 1.7 billion 1.1 billion 1.20 1.28 2.0 billion vs. Q312 +1.5% +16% +15% +20% +18% +19% +10% +21% Q1-Q313 55.8 billion 7.8 billion 5.7 billion 5.6 billion 3.7 billion 4.03 4.35 6.0 billion vs. Q1-Q312 +3% (1%) +6% (1%) (4%) (4%) +1% +19%

Sales development
Period Q313 vs. Q312 Volumes Prices (1%) Portfolio Currencies

BASF Q3 2013 Analyst Conference Call October 25, 2013

6%

1%

(5%)

Important corporate developments

Restructuring in Pigments business Optimization of global production network Reduction of 650 positions worldwide Investment of 250 million in production and R&D

Cash offer for Verenium enzyme biotechnology Cash offer of 4 US dollars per share, Offer expires on October 31, 2013 Enterprise value ~62 million US dollars Acquisition will strengthen BASFs footprint in the enzyme growth market

Transaction with Statoil completed Transaction completed July 31, 2013 Increased production from 3,000 to ~40,000 boe per day in Norway Compensation payment of 781 million US dollars*

* Euro/dollar exchange rate July 31, 2013: 1= $1.3275 BASF Q3 2013 Analyst Conference Call October 25, 2013 4

Chemicals
Pressure on volumes and margins
Q313 segment sales (million ) vs. Q312
Intermediates 700 (7%) Monomers 1,599 (11%)

EBIT before special items (million )

800 650 600 400 200 569 445 495 527

4,224 (8%)
Petrochemicals 1,925 (6%)

0 Q3 Q4 Q1 Q2 Q3

2012

2013

Sales development
Period Q313 vs. Q312 Volumes (2%) Prices (3%) Portfolio 0% Currencies (3%)

BASF Q3 2013 Analyst Conference Call October 25, 2013

Performance Products
Growth in volumes and earnings
Q313 segment sales (million ) vs. Q312
Care Chemicals 1,209 (1%) Nutrition & Health 540 +10% Paper Chemicals 365 (8%) Performance Chemicals 896

EBIT before special items (million )

600 379 394 376

3,939 (1%)

(3%)

400

344 183

200

Dispersions & Pigments 929 (2%)

0 Q3 Q4 Q1 Q2 Q3

2012

2013

Sales development
Period Q313 vs. Q312 Volumes 6% Prices (3%) Portfolio 1% Currencies (5%)

BASF Q3 2013 Analyst Conference Call October 25, 2013

Functional Materials & Solutions

Sound overall demand, especially in automotive
Q313 segment sales (million ) vs. Q312
Performance Materials 1,669 +5% Construction Chemicals 576

EBIT before special items (million )

600 400 231 200 0 Q3 Q4 Q1 Q2 Q3 228 239

4,439 +3%

(9%)

293

300

Catalysts 1,466 +12%

Coatings 728 (5%)

2012

2013

Sales development
Period Q313 vs. Q312 Volumes 8% Prices 2% Portfolio (1%) Currencies (6%)

BASF Q3 2013 Analyst Conference Call October 25, 2013

Agricultural Solutions
Sales growth despite pronounced currency headwinds
Q313 segment sales (million ) vs. Q312
1.200 900 600 300 0 Q3
2012
0 100

EBIT before special items (million )

1,008

1,054

200

171

172

Q3
2013

Q3

Q3

2012

2013

Sales development
Period Q313 vs. Q312 Volumes 8% Prices 4% Portfolio 3% Currencies (10%)

BASF Q3 2013 Analyst Conference Call October 25, 2013

Oil & Gas

Substantially higher net income
Q313 segment sales (million ) vs. Q312
Natural Gas Trading 2,376 +29% Exploration & Production 754

EBIT bSI/Net income (million )

499

500 400

422

3,130 +25%

+15%
300
396 360

200 318 100 103 0 Q3/2012 Net Income

Exploration & Production Natural Gas Trading Net income

451

62 Q3/2013 Net Income

Sales development
Period Q313 vs. Q312 Volumes 22% Prices/Currencies (2%) Portfolio 5%

BASF Q3 2013 Analyst Conference Call October 25, 2013

Review of Other
Million Sales EBIT before special items Thereof Corporate research Group corporate costs Currency result, hedges and other Valuation effects Other business Special items EBIT Q313 947 (105) (90) (57) (74) 59 (24) (129) Q312 1,087 (343) (95) (63) (249) 30 (44) (387)

BASF Q3 2013 Analyst Conference Call October 25, 2013

10

Cash Flow
Excellent cash flow in Q1-Q3 2013
Million
Cash provided by operating activities Thereof Changes in net working capital Miscellaneous items Cash provided by investing activities thereof Payments related to tangible / intangible assets Acquisitions / divestitures Cash used in financing activities thereof Changes in financial liabilities Dividends

Q1-Q313
5,982 374 (327) (4,629) (3,038) (1,093) (1,300) 1,304 (2,604)

Q1-Q312
5,025 (639) (450) (2,018) (2,702) 411 (3,383) (868) (2,510)

Q1-Q3 2013 Net working capital decreased Increased capex at 3 billion Strong free cash flow of 2.9 billion against 2.3 billion in 2012 Equity ratio of 41%; net debt increased by 1.8 billion to 13 billion
BASF Q3 2013 Analyst Conference Call October 25, 2013 11

Outlook 2013
Outlook 2013

We do not anticipate an acceleration of global economic growth in the 4th quarter of 2013 For the full year, BASF confirms its outlook: We strive to exceed the record levels in sales and
EBIT before special items in a challenging economic environment

Our focus on growth markets and innovation, in combination with our measures to optimize
our portfolio and to improve operational excellence, will contribute to this

We aim to earn a high premium on cost of capital in 2013

Assumptions 2013 GDP: Industrial production: Chemical production: US$ / Euro: Oil price (US$ / bbl):
BASF Q3 2013 Analyst Conference Call October 25, 2013

+2.0% (unchanged) +2.7% (unchanged) +3.1% (unchanged) 1.30 105 (unchanged) (unchanged)
12

13